Trade PCVX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Vaxcyte, Inc. (PCVX) is trading at US$58.13, down 3.71% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$9.32B. Over the past 52 weeks, PCVX has traded between US$31.51 and US$65.00. On Syfe you can trade PCVX with $0 commission and add it to your watchlist.
| Previous close | US$60.37 |
|---|---|
| Market cap | US$9.32B |
| 52-week range | US$31.51 – US$65.00 |
| Volume | 2.7M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Vaxcyte, Inc.
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Year: 2020
Vaxcyte Insider Sold Shares Worth $1,338,270, According to a Recent SEC Filing
Jun 29, 7:37 AM · MT Newswires
Vaxcyte Insider Sold Shares Worth $1,284,205, According to a Recent SEC Filing
Jun 22, 8:06 AM · MT Newswires
Vaxcyte Doses First Participant in Phase 1 Trial of Group A Strep Vaccine Candidate VAX-A1
Jun 2, 8:46 PM · MT Newswires
Vaxcyte, Inc. (PCVX) stock is trading at US$58.13, -3.71% from the previous close of US$60.37.
The market cap for Vaxcyte, Inc. (PCVX) stock is approximately US$9.32B.
The 52-week high for Vaxcyte, Inc. (PCVX) stock is US$65.00.
The 52-week low for Vaxcyte, Inc. (PCVX) stock is US$31.51.
Vaxcyte, Inc. (PCVX) does not currently pay a dividend.
Stay on top of PCVX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
